Wed, January 18, 2012
Tue, January 17, 2012
Mon, January 16, 2012
Fri, January 13, 2012
[ Fri, Jan 13th 2012 ] - Market Wire
January 30, 2012
Thu, January 12, 2012
Wed, January 11, 2012
Tue, January 10, 2012
Mon, January 9, 2012
Sun, January 8, 2012
Sat, January 7, 2012
Fri, January 6, 2012
Thu, January 5, 2012
Wed, January 4, 2012
Tue, January 3, 2012

The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Inhibite


//health-fitness.news-articles.net/content/2012/ .. -of-fiduciary-duty-by-the-board-of-inhibite.html
Published in Health and Fitness on Monday, January 9th 2012 at 20:20 GMT by Market Wire   Print publication without navigation


NEW YORK--([ ])--Levi & Korsinsky is investigating the Board of Directors of Inhibitex, Inc. (aInhibitexa or the aCompanya) (Nasdaq: INHX) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Bristol-Myers Squibb Co. (NYSE: BMY). Under the terms of the transaction, Inhibitex shareholders will receive $26 per share of Inhibitex stock they own. The transaction has a total approximate value of $2.5 billion. Shareholders with beneficial ownership of approximately 17% of Inhibitex common stock have already entered into agreements with Bristol-Myers to support the transaction and to tender their shares in the tender offer.

Click here to learn how to join the action: [ http://www.zlk.com/inhibitex-inhx ], or call: 877-363-5972.

The investigation concerns whether the Inhibitex Board of Directors breached their fiduciary duties to Inhibitex stockholders by failing to adequately shop the Company before entering into this transaction and whether Bristol-Myers Squibb Co. is underpaying for Inhibitex shares, thus unlawfully harming Inhibitex stockholders.

If you own common stock in Inhibitex and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at [ jlevi@zlk.com ] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or [ http://www.zlk.com ].

Levi & Korsinsky has extensive expertise in prosecuting investor securities litigation involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.


Publication Contributing Sources